Crescent Capital (CCAP) | Stock Overview & Key Data
Crescent Capital Performance Comparison
Stock Range
Today's Range
Low: $15.12
High: $15.38
on August 19, 2025
52 Week Range
Low: $13.54
High: $20.19
on April 9, 2025
on February 18, 2025
All-Time High: $21.24 on October 11, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$562.2M
EPS
1.19
P/E Ratio (TTM)
12.75
Forward P/E
7.51
P/B Ratio
0.78
PEG Ratio
-0.50
Div. Yield
16.67%
ROE
5.98%
Beta
0.597
Debt to Equity
122.44
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
75.45%
Profit Margin
24.12%
Returns and Earnings
Return on Assets (TTM)
5.27%
Return on Equity (TTM)
5.98%
EBITDA
$0
Net Income (TTM)
$44.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$4.94
Quarterly Revenue Growth (YoY)
-12.20%
Quarterly Earnings Growth (YoY)
-26.40%
Dividend Information
Last 12-Month Dividend
$2.41
Current Dividend Yield
16.67%
3-Year Average Dividend Yield
1.65%
3-Year Average Annual Dividend
$2.04
3-Year Total Dividends
$6.12
Ex-Dividend Date
August 29, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Crescent Capital CCAP | 562.22M Small-cap | 3.84% | 5.20% | -2.88% | -24.20% | -21.08% | -17.43% | -13.02% | 24.16% |
| BlackRock BLK | 175.93B Large-cap | -2.69% | 3.24% | 13.57% | 14.41% | 10.92% | 27.82% | 66.82% | 87.75% |
| Brookfield BN | 103.45B Large-cap | -1.66% | -2.80% | 8.59% | 6.53% | 12.02% | 31.28% | 62.15% | 128.94% |
| WisdomTree WT | 1.97B Small-cap | -1.25% | 3.79% | 36.24% | 43.22% | 32.74% | 31.18% | 166.80% | 246.77% |
| SRH Total Return STEW | 1.73B Small-cap | 1.52% | 2.49% | 1.34% | 6.47% | 13.49% | 16.86% | 45.18% | 75.12% |
| Sprott SII | 1.70B Small-cap | -5.59% | -16.40% | 10.98% | 45.27% | 43.84% | 46.91% | 71.91% | 47.53% |
Ownership & Short Interest
Insider Ownership
12.55%
Institutional Ownership
65.07%
Shares Short
121K
Short Ratio
0.44
Short % of Shares Outstanding
0.52%
Average 10-Day Volume
165K
Average 90-Day Volume
229K
Crescent Capital Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Crescent Capital would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CCAP's 52-week high and low?
- In the last 52 weeks, Crescent Capital reached a high of $20.19 (on February 18, 2025) and a low of $13.54 (on April 9, 2025).
- What is the market cap and P/E ratio for CCAP?
- Curious about Crescent Capital's size and valuation? Its market capitalization stands at 562.22M. When it comes to valuation, the P/E ratio (trailing twelve months) is 12.75, and the forward P/E (looking ahead) is 7.51.
- Does CCAP pay dividends? If so, what's the yield?
- Yes, Crescent Capital is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 16.67%, and the company has paid an average of $2.04 per share annually over the past 3 years.
- Who are Crescent Capital's main competitors or similar companies to consider before investing?
When looking at Crescent Capital, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return BlackRock
BLK175.93B Financial Services Asset Management 27.82% 66.82% Brookfield
BN103.45B Financial Services Asset Management 31.28% 62.15% WisdomTree
WT1.97B Financial Services Asset Management 31.18% 166.80% SRH Total Return
STEW1.73B Financial Services Asset Management 16.86% 45.18% Sprott
SII1.70B Financial Services Asset Management 46.91% 71.91% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Crescent Capital BDC, Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Crescent Capital's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 5.98%, the Debt to Equity ratio from the most recent quarter is 122.44, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for CCAP?
- Looking at Crescent Capital's growth, its revenue over the trailing twelve months (TTM) was $183M. Compared to the same quarter last year (YoY), quarterly revenue grew by -12.20%, and quarterly earnings saw a YoY growth of -26.40%.
- How much of CCAP stock is held by insiders and institutions?
- Wondering who owns Crescent Capital stock? Company insiders (like executives and directors) hold about 12.55% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 65.07%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.